Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis

[1]  J. Docampo,et al.  Autologous Mesenchymal Stem Cells for the Treatment of Amyotrophic Lateral Sclerosis , 2020, Stem Cell and Regenerative Medicine.

[2]  Jeffrey A. Cohen,et al.  Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis , 2018, Multiple sclerosis.

[3]  G. Comi,et al.  Evolving concepts in the treatment of relapsing multiple sclerosis , 2017, The Lancet.

[4]  Jeffrey A. Cohen,et al.  Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function , 2017, The Lancet.

[5]  E. Mazzon,et al.  The secretome of periodontal ligament stem cells from MS patients protects against EAE , 2016, Scientific Reports.

[6]  S. Sadiq,et al.  Clinical safety of intrathecal administration of mesenchymal stromal cell-derived neural progenitors in multiple sclerosis. , 2016, Cytotherapy.

[7]  Jonathan M. Morris,et al.  Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS , 2016, Neurology.

[8]  Yang-yang Huang,et al.  The role of growth factors as a therapeutic approach to demyelinating disease , 2016, Experimental Neurology.

[9]  A. Zander,et al.  Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted Mice. , 2016, Stem cells and development.

[10]  Hyun Young Kim,et al.  Phase I Trial of Repeated Intrathecal Autologous Bone Marrow‐Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis , 2015, Stem cells translational medicine.

[11]  B. Trapp,et al.  Pathological mechanisms in progressive multiple sclerosis , 2015, The Lancet Neurology.

[12]  E. Andreu,et al.  Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis , 2014, PloS one.

[13]  B. Nilsson,et al.  Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties ? , 2022 .

[14]  C. Bernard,et al.  Distinct Immunomodulatory and Migratory Mechanisms Underpin the Therapeutic Potential of Human Mesenchymal Stem Cells in Autoimmune Demyelination , 2013, Cell transplantation.

[15]  M. Sahraian,et al.  Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study. , 2012, Current stem cell research & therapy.

[16]  L. Aigner,et al.  Mesenchymal stem cells prime proliferating adult neural progenitors toward an oligodendrocyte fate. , 2012, Stem cells and development.

[17]  S. Sadiq,et al.  Characterization of Autologous Mesenchymal Stem Cell‐Derived Neural Progenitors as a Feasible Source of Stem Cells for Central Nervous System Applications in Multiple Sclerosis , 2012, Stem cells translational medicine.

[18]  Arnold I Caplan,et al.  Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models , 2012, Nature Neuroscience.

[19]  S. Sadiq,et al.  Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis , 2012, Journal of the Neurological Sciences.

[20]  Benjamin E. Deverman,et al.  Exogenous Leukemia Inhibitory Factor Stimulates Oligodendrocyte Progenitor Cell Proliferation and Enhances Hippocampal Remyelination , 2012, The Journal of Neuroscience.

[21]  David H. Miller,et al.  Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study , 2012, The Lancet Neurology.

[22]  R. Romieu-Mourez,et al.  Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing , 2011, Cytotherapy.

[23]  H. Lassmann,et al.  Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis , 2011, Experimental Neurology.

[24]  S. Sadiq,et al.  Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated mice. , 2011, Stem cells and development.

[25]  M. Chopp,et al.  Endogenous Tissue Plasminogen Activator Mediates Bone Marrow Stromal Cell-Induced Neurite Remodeling After Stroke in Mice , 2011, Stroke.

[26]  Jeff W M Bulte,et al.  Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. , 2010, Archives of neurology.

[27]  R. Mahfouz,et al.  Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study , 2010, Journal of Neuroimmunology.

[28]  Michael O'Brien,et al.  Aids to the examination of the peripheral nervous system: 6th edition , 2023, Practical Neurology.

[29]  D. Covas,et al.  Mechanisms involved in the therapeutic properties of mesenchymal stem cells. , 2009, Cytokine & growth factor reviews.

[30]  X. Wen,et al.  GDNF‐enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons , 2009, Glia.

[31]  Philippe M. Campeau,et al.  Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner1 , 2009, The Journal of Immunology.

[32]  C. Shih,et al.  Derivation of neural stem cells from mesenchymal stemcells: evidence for a bipotential stem cell population. , 2008, Stem cells and development.

[33]  G. Prestwich,et al.  Recruitment of endogenous stem cells for tissue repair. , 2008, Macromolecular bioscience.

[34]  T. Ben-Hur,et al.  Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. , 2008, Archives of neurology.

[35]  A. Ghavamzadeh,et al.  Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study. , 2007, Iranian journal of immunology : IJI.

[36]  Antonio Uccelli,et al.  Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis , 2007, Annals of neurology.

[37]  A. Vercelli,et al.  Neural differentiation of human mesenchymal stem cells: Evidence for expression of neural markers and eag K+ channel types. , 2006, Experimental hematology.

[38]  C. Lois,et al.  Mesenchymal Stem Cells Instruct Oligodendrogenic Fate Decision on Adult Neural Stem Cells , 2006, Stem cells.

[39]  M. Chopp,et al.  Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice , 2006, Journal of neuroscience research.

[40]  G. Mancardi,et al.  Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. , 2005, Blood.

[41]  Yi Li,et al.  Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells , 2005, Glia.

[42]  H. Lerche,et al.  Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells , 2004, Journal of Cell Science.

[43]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[44]  M. Chopp,et al.  Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats , 2001, Journal of the Neurological Sciences.

[45]  DR McCluskey,et al.  Aids to the examination of the peripheral nervous system , 1989, Practical Neurology.

[46]  C. Zhang,et al.  Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis. , 2009, Cytotherapy.